Advancing treatments for transthyretin amyloid cardiomyopathy: Innovations in RNA silencing, gene editing, TTR stabilization, and degradation
Kardiol Pol
.
2025 Jan 7.
doi: 10.33963/v.phj.104054.
Online ahead of print.
Authors
Daria M Keller
1
,
Ewa Straburzyńska-Migaj
2
,
Maciej Lesiak
2
Affiliations
1
1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland.
[email protected]
.
2
1st Department of Cardiology, Poznan University of Medical Sciences, Poznań, Poland.
PMID:
39775625
DOI:
10.33963/v.phj.104054
No abstract available